d-alpha tocopherol has been researched along with Cardiovascular Stroke in 230 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (15.65) | 18.7374 |
| 1990's | 93 (40.43) | 18.2507 |
| 2000's | 77 (33.48) | 29.6817 |
| 2010's | 24 (10.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolkenius, FN; De Jong, W; Dow, J; Grisar, JM; Haegele, KD; Petty, MA; Wagner, ER; Wagner, J | 1 |
| Sharma, SB; Shukla, SK; Singh, UR | 1 |
| Azzi, A; Das, DK; Das, M; Lekli, I; Mukherjee, S | 1 |
| Padmanabhan, M; Prince, PS; Rajadurai, M | 1 |
| Boehm, BO; Grammer, TB; Hoffmann, MM; Kleber, M; Maerz, W; Renner, W; Winkelhofer-Roob, BM | 1 |
| Prince, PS; Punithavathi, VR | 2 |
| Blouin, K; Drechsler, C; Espe, KM; Henze, A; Hocher, B; Krane, V; Pilz, S; Raila, J; Schmiedeke, D; Schneider, A; Schweigert, FJ; Wanner, C | 1 |
| Bode, P; Fernandez-Crehuet, J; Gomez-Aracena, J; Gorgojo, L; Guillen, J; Jimenez, J; Kark, JD; Kok, FJ; Martin-Moreno, JM; Riemersma, RA; Ringstad, JJ | 1 |
| Campos, H; Gaziano, JM; Hak, AE; Ma, J; Sesso, HD; Stampfer, MJ; Willett, W | 1 |
| Muzáková, V; Rousar, T; Skalický, J; Vojtísek, P | 1 |
| Albanes, D; Huttunen, JK; Korhonen, PA; Taylor, PR; Törnwall, ME; Virtamo, J; Virtanen, MJ | 1 |
| Barancoková, M; Collins, A; Dusinská, M; Horská, A; Kazimírová, A; Raslová, K; Smolková, B; Spustová, V | 1 |
| Prince, PS; Rajadurai, M | 1 |
| Bae, SW; Choi, BY; Choi, YH; Lee, SH; Lee, YS; Pachinger, O; Park, HK; Park, JE; Stühlinger, MC; Yoo, HS; Yu, KH | 1 |
| Mainzen Prince, PS; Padmanabhan, M | 1 |
| Campolo, J; Cighetti, G; De Chiara, B; Famoso, G; Fiorentini, C; Lualdi, A; Mafrici, A; Parodi, O; Parolini, M; Sedda, V | 1 |
| Gorodetskaya, EA; Kalenikova, EI; Kolokolchikova, EG; Medvedev, OS; Shashurin, DA | 1 |
| Iskakov, KM; Rysmendiev, AZh; Tukesheva, BSh; Tulenov, MT | 1 |
| Seliger, K; Thiele, R; Tränkmann, P; Winnefeld, K | 1 |
| Cegan, A; Cervinková, Z; Kandár, R; Muzáková, V; Skalický, J; Vanková, R; Vojtísek, P | 1 |
| Casal, S; Macedo, B; Oliveira, MB | 1 |
| Blanco, I; Granado, F; Martín-Peña, G; Olmedilla, B; Ruiz Rejón, F; Ruiz-Galiana, J | 1 |
| Iskakov, KM; Konakbaeva, TN; Shokareva, GV | 1 |
| Evstigneeva, RP; Kagan, VE; Konorev, EA; Konorev, LA; Pichugin, VV; Rudnev, DV; Saks, VA; Sharov, VG | 1 |
| Wang, T; Xu, L | 1 |
| Chattipakorn, N; Chattipakorn, SC; Kaneko, S; Nagata, N; Ni, Y; Ota, T; Pongkan, W; Sugiura, M; Takamura, M; Takatori, O; Usui, S; Xu, L | 1 |
| Hu, S; Li, J; Wu, F; Zhang, S; Zhang, X | 1 |
| Jen-Kit, T; Jubri, Z; Zarkasi, KA | 1 |
| Bruckdorfer, KR; Lennon, L; Papacosta, O; Shaper, AG; Wannamethee, SG; Whincup, PH | 1 |
| Devi, S; Srinivasulu, C; Suchalatha, S | 1 |
| Bhatt, DL | 1 |
| Badavi, M; Dianat, M; Esmaeilizadeh, M; Naghizadeh, B; Samarbafzadeh, A | 1 |
| Dussaillant, G; Gárate, J; Gormaz, JG; Hasson, D; León, L; Prieto, JC; Ramos, C; Rodrigo, R; Valls, N | 1 |
| De Gaetano, G; Di Castelnuovo, A; Iacoviello, L; Loffredo, L; Perri, L; Violi, F | 1 |
| Bednarz, B; Ceremuzynski, L; Herbaczynska-Cedro, K; Jaxa-Chamiec, T; Maciejewski, P | 1 |
| Balaraman, R; Gandhi, C; Upaganlawar, A | 1 |
| Chen, CM; Cheng, ML; Chiu, DT; Ho, HY; Li, JM | 1 |
| Al-Merri, K; Al-Nemer, K; Dagenais, G; Healey, J; Lonn, E; Mann, JF; Mathew, J; Salehian, O; Sumner, G; Yi, Q | 1 |
| Cappello, S; Chegaev, K; Di Stilo, A; Fruttero, R; Gasco, A; Lazzarato, L; Rastaldo, R | 1 |
| Akhter, N; Parvin, R | 1 |
| Ahsan, MK; Bak, I; Das, DK; Gherghiceanu, M; Gurusamy, N; Juhasz, B; Lekli, I; Mukherjee, S; Popescu, LM; Ray, D; Tosaki, A | 1 |
| Bobrovová, Z; Holecková, M; Hrdina, R; Mazurová, Y; Mladenka, P; Nachtigal, P; Palicka, V; Semecky, V; Vávrová, J | 1 |
| Kumaran, KS; Prince, PS | 1 |
| Pugalendi, KV; Vennila, L | 1 |
| Asleh, R; Blum, S; Brown, JB; Levy, AP; Levy, NS; Miller-Lotan, R; Milman, U; Russell, A; Shapira, C; Vardi, M | 1 |
| Davison, A; Faloon, W; Firshein, R; Gleyzer, M; Gordon-Cohen, B; Hirsh, SP; Joyal, SV; Juhl, JH; Kulick, A; Ostrow, GL | 1 |
| Haffey, TA | 1 |
| Gaby, AR | 1 |
| Ahmed, M; Bagatini, MD; Battisti, V; da Rosa, CS; Gasparetto, D; Martins, CC; Morsch, VM; Schetinger, MR; Schmatz, R; Spanevello, RM | 1 |
| Chen, SY; Hsu, DZ; Liu, MY; Periasamy, S | 1 |
| Albert, CM; Buring, JE; Chae, CU; Conen, D; Everett, BM; Glynn, RJ; Tedrow, UB | 1 |
| Chen, C; Koh, WP; Lee, YP; Naidoo, N; Ong, CN; van Dam, RM; Yuan, JM | 1 |
| Blum, S; Levy, AP; Vardi, M | 1 |
| Chen, Y; Davis-Gorman, G; McDonagh, PF; Watson, RR | 1 |
| Bosch, J; Dagenais, G; Gerstein, HC; Hoogwerf, B; Lonn, E; Mann, JF; Pogue, J; Yi, Q; Yusuf, S; Zinman, B | 1 |
| Marchioli, R | 1 |
| Freudenheim, JL; Hovey, K; McCann, SE; Muti, P; Nochajski, TH; Ram, M; Russell, M; Sempos, C; Trevisan, M | 1 |
| Kartikey, K; Kumar, A; Neki, NS; Niaz, MA; Pella, D; Singh, RB; Thakur, AS | 1 |
| SoRelle, R | 1 |
| PREZIOSI, P | 1 |
| BERRYMAN, GH; BOCKMAN, AA; MELTZER, LE | 1 |
| PELKONEN, R | 1 |
| LELEK, I; PALFY, A | 1 |
| GATI, T; HARMOS, G; KEMENY, T; RIGO, J; SIMON, G; SOS, J | 1 |
| DALDERUP, LM; DEN HARTOG, C; POL, G | 1 |
| Bednarz, B; Ceremuzyński, L; Chamiec, T | 1 |
| Albertini, F; Archetti, S; Assanelli, D; Bonanome, A; Grassi, M; Maccalli, P; Negrini, R; Pezzini, A; Visioli, F | 1 |
| Ascherio, A; Hu, FB; Merchant, AT; Rimm, EB; Spiegelman, D; Willett, WC | 1 |
| Crean, P; Foley, JB; McCarroll, N; Mulvihill, NT; Murphy, A; Murphy, RT; Tome, MT; Walsh, MJ | 1 |
| Coulter, I; Hardy, M; J Suttorp, M; Jungvig, LK; Morton, SC; Newberry, SJ; Shekelle, PG; Spar, M; Tu, W; Udani, J | 1 |
| Arya, DS; Dinda, A; Gupta, SK; Joshi, S; Mohanty, I; Talwar, KK | 1 |
| Bosch, J; Dagenais, GR; Gerstein, HC; Hoogwerf, BJ; Lonn, EM; Mann, JF; Pogue, J; Yi, Q; Yusuf, S | 1 |
| Arya, DS; Bansal, P; Dinda, A; Gupta, SK; Joshi, S; Mohanty, I; Saxena, A; Talwar, KK | 1 |
| Eidelman, RS; Hebert, PR; Hennekens, CH; Hollar, D; Lamas, GA | 1 |
| Basu, S; Berg, K; Bjerve, K; Brurok, H; Gunnes, S; Jynge, P; Skarra, S; Wiseth, R | 1 |
| Hata, K; Inoue, N; Masai, H; Matsumoto, H; Ozawa, T; Shinke, T; Takaoka, H; Watanabe, S; Yokoyama, M; Yoshikawa, R | 1 |
| Pugalendi, KV; Ramakrishna Rao, M; Senthil, S; Veerappan, RM | 1 |
| Accinni, R; Bonacina, E; Brenna, S; Pinelli, A; Tomasoni, L; Trivulzio, S | 1 |
| Dagenais, GR; Lonn, E; Ostergren, J; Sleight, P; Yi, Q; Yusuf, S | 1 |
| Al-Omran, MA; Alkhenizan, AH | 1 |
| Cervinková, Z; Meloun, M; Muzáková, V; Rousar, T; Vanková, R; Vojtísek, P | 1 |
| Gorman, C | 1 |
| Bednarz, B; Drozdowska, D; Gessek, J; Gniot, J; Janik, K; Jaxa-Chamiec, T; Kawka-Urbanek, T; Maciejewski, P; Ogórek, M; Szpajer, M | 1 |
| Bosch, J; Gerstein, HC; Lonn, E; McQueen, MJ; Yusuf, S | 1 |
| Levantesi, G; Macchia, A; Marchioli, R; Marfisi, RM; Nicolosi, GL; Tavazzi, L; Tognoni, G; Valagussa, F | 1 |
| Dong, E; Liu, W; Patel, R; Qin, F; Yan, C | 1 |
| Balion, C; Bickel, C; Blankenberg, S; Cambien, F; Gerstein, H; Lonn, E; McQueen, MJ; Münzel, T; Pogue, J; Rupprecht, HJ; Smieja, M; Tiret, L; Yusuf, S | 1 |
| Buring, JE | 1 |
| Boza, JJ; Carrero, JJ; Fonollá, J; Jiménez, J; López-Huertas, E; Marti, JL | 1 |
| Borrelli, G; Chieffo, C; Franzosi, MG; Levantesi, G; Maggioni, AP; Marchioli, R; Marfisi, RM; Nicolosi, GL; Scarano, M; Schweiger, C; Silletta, MG; Tavazzi, L; Tognoni, G | 1 |
| Martin, W | 1 |
| Frolov, VA; Kapustin, VA | 1 |
| Burlakova, EB; Kalmykova, VI | 1 |
| Goto, Y | 1 |
| Barth, JD; Elliott, TG; Mancini, GB | 1 |
| Bellows, SD; Hale, SL; Kay, GL; Kloner, RA; Simkhovich, BZ | 1 |
| Caldarera, CM; Giordano, E; Guarnieri, C; Muscari, C | 1 |
| Agarwal, P; Begom, R; Niaz, MA; Rastogi, SS; Singh, RB | 1 |
| Begom, R; Bishnoi, I; Kumar, R; Niaz, MA; Sharma, JP; Singh, RB | 1 |
| Aro, A; Delgado-Rodriguez, M; Gomez-Aracena, J; Kardinaal, AF; Kark, JD; Kohlmeier, L; Kok, FJ; Martin, BC; Mazaev, VP; Ringstad, J | 1 |
| Döring, A; Hense, HW | 1 |
| D'Onofrio, F; Galzerano, D; Gambardella, A; Paolisso, G; Varricchio, M | 1 |
| Canet, E; de Lorgeril, M; Delaye, J; Forrat, R; Renaud, S; Sebbag, L | 1 |
| Bumbacher, B; Gutzwiller, F; Gyurech, D; Martin, B; Schilling, J | 1 |
| Balla, G; Balla, J; Belcher, JD; Jacob, HS; Vercellotti, GM | 1 |
| Comstock, GW; Klag, MJ; Salkeld, RM; Schüep, W; Street, DA | 1 |
| Di Pasquale, A; Marchioli, R | 1 |
| Aro, A; Delgado-Rodriguez, M; Gómez-Aracena, J; Hallen, M; Huttunen, JK; Kardinaal, AF; Kohlmeier, L; Kokl, FJ; Martin-Moreno, JM; van 't Veer, P | 1 |
| Bors, W; Hense, HW; Keil, U; Stender, M | 1 |
| Kok, FJ | 1 |
| Adgey, AA; Lightbody, JH; Purvis, JA; Trimble, ER; Young, IS | 1 |
| Klein, HH; Lindert-Heimberg, S; Nebendahl, K; Niedmann, P; Pich, S | 1 |
| Bolkenius, FN; De Jong, W; Dow, J; Grisar, JM; Lukovic, L; Petty, MA | 1 |
| Hill, MF; Singal, PK | 1 |
| Chisolm, GM; Lafont, A; Marwick, TH; Van Lente, F; Vaska, KJ; Whitlow, PL | 1 |
| Coudray, C; de Leiris, J; Favier, A; Machecourt, J; Pucheu, S; Vanzetto, G | 1 |
| Båvenholm, P; Hamsten, A; Moldeus, P; Nilsson, J; Regnström, J; Ström, K; Tornvall, P | 1 |
| Niaz, MA; Rastogi, S; Rastogi, SS; Singh, RB | 1 |
| Ceremuzyński, L; Chamiec, T; Herbaczyńska-Cedro, K | 1 |
| Cheeseman, K; Kelly, F; Mitchinson, MJ; Parsons, A; Schofield, PM; Stephens, NG | 1 |
| Leake, DS | 1 |
| Purvis, JA; Vallely, SR; Young, IS | 1 |
| Mörike, EM | 1 |
| Polasek, J | 2 |
| Avci, N; Torun, M; Yardim, S | 1 |
| Aro, A; Berglund, L; Lithell, H; Ohrvall, M; Salminen, I; Vessby, B | 1 |
| Ithayarasi, AP; Padmavathy, VN; Shyamala Devi, C | 1 |
| Katori, M; Kuribayashi, Y; Majima, M; Yoshida, K | 1 |
| Conti, CR | 1 |
| de Jong, W; Jones, CR; Lukovic, L; Petty, MA | 1 |
| Cedro, K; Herbaczyńska-Cedro, K; K+osiewicz-Wasek, B; Panczenko-Kresowska, B; Wartanowicz, M; Wasek, W | 1 |
| Heinzl, S | 1 |
| Stephens, N | 1 |
| Albanes, D; Heinonen, OP; Huttunen, JK; Rapola, JM; Ripatti, S; Taylor, PR; Virtamo, J | 2 |
| Shahar, E | 1 |
| López Manglano, C; Martín Peña, G; Ruiz Galiana, J; Ruiz Rejón, F; Seijas Martínez, V | 1 |
| Agarwal, R; Anand, CV; Anand, U; Chandrika, C | 1 |
| Aho, K; Haukka, J; Palosuo, T; Puurunen, M; Taylor, PR; Vaarala, O; Virtamo, J | 1 |
| Altavilla, D; Avenoso, A; Campo, GM; Campo, S; Caputi, AP; Ferlito, M; Squadrito, F; Squadrito, G | 1 |
| Day, BW; Evans, RW; Kuller, LH; Shaten, BJ | 1 |
| Boev, SS; Selivonenko, VG | 1 |
| Rydén, L; Shimizu, M; Sjöquist, PO; Wang, QD | 1 |
| Kyuki, K; Ogata, K; Sakaue, T; Yamada, S; Yamaguchi, K; Yashita, T | 1 |
| Albanes, D; Haukka, JK; Heinonen, OP; Huttunen, JK; Rapola, JM; Ripatti, S; Taylor, PR; Virtamo, J | 1 |
| Aristides, M; Davey, PJ; Dobson, M; Gliksman, M; Schulz, M; Stephens, NG | 1 |
| Durić, J; Dusinović, S; Mijalković, D; Niketić, V; Saicić, ZS; Spasić, MB; Zunić, Z | 1 |
| Altavilla, D; Avenoso, A; Campo, GM; Campo, S; Caputi, AP; Ceccarelli, S; Ferlito, M; Quartarone, C; Saitta, A; Squadrito, F; Squadrito, G | 1 |
| Ithayarasi, AP; Shyamala Devi, C | 1 |
| Bui, M; Gomez-Aracena, J; Kardinaal, A; Kohlmeier, L; Kok, F; Martin, B; Martin-Moreno, J; Simonsen, N; Strain, S; Su, LC; Thamm, M; van't Veer, P | 1 |
| Bligh, E; Brown, MJ; Mitchinson, MJ; Parsons, A; Schofield, PM; Stephens, NG | 1 |
| Boeing, H; den Breeijen, JH; Geleijnse, JM; Grobbee, DE; Hofman, A; Klipstein-Grobusch, K; Witteman, JC | 1 |
| Hegde, BM; Tripathi, Y | 1 |
| Devi, CS; Ithayarasi, AP | 1 |
| Titus, K | 1 |
| Carrasquedo, F; Fraga, CG; Glanc, M | 1 |
| Garewal, HS; Hoffman, RM | 1 |
| Ness, A; Smith, GD | 1 |
| Brown, M | 1 |
| Bayindir, O; Boydak, B; Güner, I; Kumanlioğlu, K; Mutaf, I; Ozmen, D; Zoghi, M | 1 |
| Devaraj, S; Huet, BA; Jialal, I; Traber, M | 1 |
| de Lorgeril, M; Salen, P | 1 |
| Lau, CP; Ng, W; Tse, HF | 1 |
| Ebrahim, S; Higgins, JP; Hopper, L; Moore, T; Ness, A | 1 |
| Steiner, M | 1 |
| Lenhart, SE; Nappi, JM | 1 |
| Erkkilä, AT; Lehto, S; Närvänen, O; Uusitupa, MI; Ylä-Herttuala, S | 1 |
| Bosch, J; Dagenais, G; Pogue, J; Sleight, P; Yusuf, S | 1 |
| Dhalla, NS; Nagano, M; Sethi, R; Takeda, N | 1 |
| Daga, MK; Malhotra, R; Mishra, TK; Prabash, K | 1 |
| Marchioli, R; Valagussa, F | 1 |
| Rand, PJ; Schooff, M | 1 |
| Stone, NJ | 1 |
| Cordan, J; Dirican, M; Güllülü, S; Serdar, A; Serdar, Z; Yesilbursa, D | 1 |
| Chamblee, BB; Hunsaker, LA; Timm, TC; Vander Jagt, DL | 1 |
| Kharb, S; Singh, GP | 1 |
| Steinberg, D | 1 |
| Blann, AD; Landray, MJ; Lip, GY; Lydakis, C; Nuttall, SL; Watson, RD | 1 |
| Albanes, D; Häkkinen, S; Hirvonen, T; Ovaskainen, ML; Pietinen, P; Virtamo, J; Virtanen, M | 1 |
| Madsen, S; Reikvam, A | 1 |
| Aggarwal, HK; Budhiraja, N; Nand, N; Sharma, M; Singh, GP | 1 |
| Kharb, S; Singh, V | 1 |
| Ghalaut, PS; Kharb, S; Singh, GP; Singh, V | 1 |
| Costantini, F; Cuccurullo, F; Fellin, R; Mezzetti, A; Pierdomenico, SD; Romano, F; Zuliani, G | 1 |
| Cramb, R | 1 |
| Nordt, T | 1 |
| Marchioli, R; Schweiger, C; Tavazzi, L; Valagussa, F | 1 |
| Bastagi, L; Boni, P; Massarelli, G; Muscari, A; Poggiopollini, G; Puddu, P; Tomassetti, V | 1 |
| Eikelboom, JW; Hirsh, J; Johnston, M; Weitz, JI; Yi, Q; Yusuf, S | 1 |
| Beskrovnova, NN; Kogan, AKh; Korolev, VV; Kudrin, AN; Nikolaev, SM | 1 |
| Naess, K | 2 |
| Beskrovnova, NN; Kakurskiĭ, LV; Kogan, AKh; Kudrin, AN; Nikolov, SM | 1 |
| Dzizinskiĭ, AA; Katiubin, VP | 2 |
| De Jong, W; Grisar, JM; Petty, MA | 1 |
| Downey, JM; Janero, DR; Ooiwa, H; Stanley, AW | 1 |
| Axford-Gatley, RA; Wilson, GJ | 1 |
| Ciavatti, M; de Lorgeril, M; Delaye, J; Ovize, A; Ovize, M; Renaud, S | 1 |
| Iabluchanskiĭ, NI; Makhalova, TV; Pavlenko, LA; Sokrut, VN | 1 |
| De Jong, W; Dow, J; Grisar, JM; Petty, MA | 1 |
| Iabluchanskiĭ, NI; Libman, TIa; Sokrut, VN; Zhdaniuk, IuI | 1 |
| Sinitsyn, SP | 1 |
| Engibarian, AA; Karagezian, KG; Varosian, MA | 1 |
| Amatuni, VG; Matevosian, RSh | 1 |
| Ana'nev, AA; Dzizinskiĭ, AA; Fuks, AR | 1 |
| Kumari, SS; Menon, VP; Muraleedharan, D; Varghese, A | 1 |
| Shekhunova, IA | 1 |
| Kito, G; Tanabe, M | 1 |
| Klein, HH; Kreuzer, H; Lindert, S; Nebendahl, K; Niedmann, P; Pich, S | 1 |
| Holdaway, I; Jackson, R; Scragg, R; Woollard, D; Woollard, G | 1 |
| Fantone, JC; Ward, PA | 1 |
| Akesson, B; Arnesen, H; Aursnes, I; Smith, P | 1 |
| Badalian, GO; Danilova, LL; Karagezian, KG; Ordian, VV; Ovakimian, SS | 1 |
| Brink, PA; Labadarios, D; Louw, ME; Shephard, GS; van Stuijvenberg, ME; Visser, L; Weich, HF | 1 |
| Abbud, A; Dudaev, VA; Ivanov, AS | 1 |
| Aznaurian, AV; Engibarian, AA; Tumanian, EL | 1 |
| Chebotarev, AA; Davydov, BV; Golikov, AP; Golikov, PP; Polumiskov, VIu | 1 |
| Li, CP; Li, RC | 1 |
| Elmfeldt, D; Holm, T; Korsan-Bengtsen, K | 1 |
| Dalderup, LM | 1 |
| Vogelsang, A | 1 |
| Folkers, K; Nilsson, IM; Nilsson, JL; Redalieu, E | 1 |
18 review(s) available for d-alpha tocopherol and Cardiovascular Stroke
| Article | Year |
|---|---|
Molecular Understanding of the Cardiomodulation in Myocardial Infarction and the Mechanism of Vitamin E Protections.
Topics: Animals; Antioxidants; Cell Survival; Humans; Myocardial Infarction; Protective Agents; Signal Transduction; Vitamin E | 2019 |
Supplementation with vitamin E alone is associated with reduced myocardial infarction: a meta-analysis.
Topics: Antioxidants; Dietary Supplements; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Vitamin E | 2015 |
How to avoid a heart attack: putting it all together.
Topics: Ascorbic Acid; Dietary Supplements; Evidence-Based Medicine; Humans; Myocardial Infarction; Osteopathic Physicians; Physician-Patient Relations; Risk Factors; Vitamin B Complex; Vitamin E; Vitamins | 2010 |
Nutritional treatments for acute myocardial infarction.
Topics: Antioxidants; Ascorbic Acid; Carnitine; Dietary Supplements; Humans; Magnesium; Myocardial Infarction; Oxidative Stress; Primary Prevention; Ubiquinone; United States; Vitamin B Complex; Vitamin E | 2010 |
Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature.
Topics: Antioxidants; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Genotype; Haptoglobins; Humans; Myocardial Infarction; Pharmacogenetics; Risk Factors; Stroke; Vitamin E | 2012 |
Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease.
Topics: Cardiovascular Diseases; Cause of Death; Dietary Supplements; Evidence-Based Medicine; Fatty Acids, Omega-3; Humans; Lipids; Myocardial Infarction; Randomized Controlled Trials as Topic; Survival Analysis; Vitamin E | 2004 |
Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease.
Topics: Adult; Aged; Cardiovascular Diseases; Death, Sudden, Cardiac; Female; Humans; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Vitamin E | 2004 |
The role of vitamin E in the prevention of coronary events and stroke. Meta-analysis of randomized controlled trials.
Topics: Antioxidants; Coronary Disease; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome; Vitamin E | 2004 |
[The biochemical, pharmacological and epidemiological reference picture of the GISSI-Prevention. The Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
Topics: Cholesterol; Fatty Acids, Omega-3; Female; Humans; Italy; Male; Myocardial Infarction; Streptokinase; Vitamin E | 1993 |
Prospective association between lipid soluble antioxidants and coronary heart disease in men. The Multiple Risk Factor Intervention Trial.
Topics: Adult; Antioxidants; Carotenoids; Cohort Studies; Coronary Disease; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Statistical Distributions; Vitamin A; Vitamin E | 1998 |
A panorama of cardiac risk.
Topics: Adult; Aged; Amyloid; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Prospective Studies; Research; Retrospective Studies; Risk Factors; Time Factors; Triglycerides; Vitamin E | 1999 |
GISSI-Prevenzione trial.
Topics: Fatty Acids, Omega-3; Fish Oils; Humans; Myocardial Infarction; Survival Analysis; Vitamin E | 1999 |
Vitamins for the management of cardiovascular disease: a simple solution to a complex problem?
Topics: Antioxidants; Cardiovascular Diseases; Clinical Trials as Topic; Homocysteine; Humans; Myocardial Infarction; Vitamin B Complex; Vitamin E; Vitamins | 1999 |
The results of the GISSI-Prevenzione trial in the general framework of secondary prevention.
Topics: Fatty Acids, Omega-3; Humans; Myocardial Infarction; Preventive Medicine; Randomized Controlled Trials as Topic; Vitamin E | 2000 |
The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardio (GISSI)-Prevenzione Trial on fish oil and vitamin E supplementation in myocardial infarction survivors.
Topics: Dietary Supplements; Fatty Acids, Omega-3; Fish Oils; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Vitamin E | 2000 |
Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis?
Topics: Animals; Antioxidants; Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Disease; Humans; Lipoxygenase; Mice; Mice, Knockout; Myocardial Infarction; Species Specificity; Stroke; Thrombosis; Vitamin E | 2000 |
[How should ACE inhibitors be used in myocardial infarction?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Follow-Up Studies; Humans; Myocardial Infarction; Ramipril; Randomized Controlled Trials as Topic; Risk Factors; Vitamin E | 2000 |
Polymorphonuclear leukocyte-mediated cell and tissue injury: oxygen metabolites and their relations to human disease.
Topics: Animals; Arthritis, Rheumatoid; Ascorbic Acid; Autoimmune Diseases; Ceruloplasmin; Chemotactic Factors; Cricetinae; Cricetulus; Free Radicals; Humans; Immune Complex Diseases; Inflammation; Lipid Peroxides; Myocardial Infarction; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Oxidation-Reduction; Oxygen; Pancreatic Elastase; Peroxidase; Peroxidases; Peroxides; Phagocytosis; Pulmonary Emphysema; Respiratory Distress Syndrome; Superoxide Dismutase; Superoxides; Vasculitis; Vitamin E | 1985 |
44 trial(s) available for d-alpha tocopherol and Cardiovascular Stroke
| Article | Year |
|---|---|
Low plasma α-tocopherol concentrations and adverse clinical outcomes in diabetic hemodialysis patients.
Topics: Aged; alpha-Tocopherol; Biomarkers; Cause of Death; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Communicable Diseases; Confounding Factors, Epidemiologic; Diabetic Nephropathies; Down-Regulation; Female; Germany; Humans; Kaplan-Meier Estimate; Male; Malnutrition; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Prospective Studies; Renal Dialysis; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome | 2013 |
Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study.
Topics: Aged; alpha-Tocopherol; Antioxidants; beta Carotene; Coronary Disease; Dietary Supplements; Double-Blind Method; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Smoking; Survival Analysis | 2004 |
Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk.
Topics: alpha-Tocopherol; Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Dietary Supplements; DNA Damage; Folic Acid; Folic Acid Deficiency; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Micronucleus Tests; Middle Aged; Myocardial Infarction; Oxidative Stress; Selenium | 2004 |
[Effect of administration of selenium and vitamin E on heart failure and ventricular arrhythmias in patients with acute myocardial infarct].
Topics: Adult; Aged; alpha-Tocopherol; Antioxidants; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Sodium Selenite; Stroke Volume; Tachycardia, Ventricular; Tocopherols; Vitamin E | 1999 |
The effectiveness of antioxidant vitamins C and E in reducing myocardial infarct size in patients subjected to percutaneous coronary angioplasty (PREVEC Trial): study protocol for a pilot randomized double-blind controlled trial.
Topics: Administration, Oral; Antioxidants; Ascorbic Acid; Biomarkers; Chile; Clinical Protocols; Double-Blind Method; Drug Administration Schedule; Female; Hospitals, University; Humans; Magnetic Resonance Imaging; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Percutaneous Coronary Intervention; Pilot Projects; Research Design; Time Factors; Treatment Outcome; Vitamin E | 2014 |
The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Bundle-Branch Block; Cardiovascular Diseases; Chronic Disease; Death, Sudden; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Europe; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; North America; Proportional Hazards Models; Prospective Studies; Ramipril; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome; Vascular Diseases; Vitamin E | 2009 |
Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.
Topics: Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Heart Diseases; Humans; Male; Myocardial Infarction; Placebos; Stroke; Survival Rate; Treatment Outcome; Vitamin E | 2002 |
Effect of coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction.
Topics: Adult; Antioxidants; Arteriosclerosis; Cholesterol, HDL; Coenzymes; Double-Blind Method; Female; Humans; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Risk Factors; Thiobarbituric Acid Reactive Substances; Ubiquinone; Vitamin E | 2003 |
Antioxidant vitamins decrease exercise-induced QT dispersion after myocardial infarction.
Topics: Antioxidants; Ascorbic Acid; Double-Blind Method; Electrocardiography; Exercise Test; Female; Free Radicals; Humans; Male; Middle Aged; Myocardial Infarction; Vitamin E | 2003 |
Folic acid and vitamin E supplementation effects on homocysteinemia, endothelial function and plasma antioxidant capacity in young myocardial-infarction patients.
Topics: Adult; Antioxidants; Diagnostic Techniques and Procedures; Dietary Supplements; Drug Administration Schedule; Endothelium, Vascular; Female; Folic Acid; Gene Frequency; Genetic Markers; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Infarction; Pharmacology, Clinical; Uric Acid; Vasodilation; Vitamin E | 2004 |
Vitamin E modulation of C-reactive protein in smokers with acute coronary syndromes.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; C-Reactive Protein; Cell Adhesion Molecules; Chromatography, High Pressure Liquid; Double-Blind Method; E-Selectin; Female; Humans; Inflammation; Intercellular Adhesion Molecule-1; Male; Middle Aged; Myocardial Infarction; P-Selectin; Placebos; Prognosis; Smoking; Time Factors; Up-Regulation; Vitamin E | 2004 |
Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study.
Topics: Aged; Antioxidants; Cardiovascular Diseases; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Risk Factors; Severity of Illness Index; Stroke; Treatment Failure; Vitamin E | 2004 |
Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Cardiovascular Diseases; Female; Humans; Incidence; Male; Middle Aged; Morbidity; Myocardial Infarction; Preventive Medicine; Ramipril; Risk Factors; Smoking; Stroke; Treatment Outcome; Vitamin E | 2005 |
Antioxidant effects of combined vitamins C and E in acute myocardial infarction. The randomized, double-blind, placebo controlled, multicenter pilot Myocardial Infarction and VITamins (MIVIT) trial.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; Double-Blind Method; Drug Administration Schedule; Female; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Poland; Reactive Oxygen Species; Treatment Outcome; Vitamin E | 2005 |
The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cost-Benefit Analysis; Diabetes Complications; Female; Heart Failure; Humans; Inflammation; Kidney Diseases; Male; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Ramipril; Stroke; Ventricular Function, Left; Vitamin E | 2005 |
Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Female; Fibrinogen; Heart Diseases; Humans; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Predictive Value of Tests; Ramipril; Risk Factors; Vitamin E | 2006 |
Aspirin prevents stroke but not MI in women; vitamin E has no effect on CV disease or cancer.
Topics: Aged; Aspirin; Cardiovascular Diseases; Chemoprevention; Female; Humans; Middle Aged; Myocardial Infarction; Neoplasms; Placebos; Stroke; Vitamin E | 2006 |
Intake of fish oil, oleic acid, folic acid, and vitamins B-6 and E for 1 year decreases plasma C-reactive protein and reduces coronary heart disease risk factors in male patients in a cardiac rehabilitation program.
Topics: C-Reactive Protein; Coronary Disease; Dietary Supplements; Double-Blind Method; Fish Oils; Folic Acid; Humans; Male; Middle Aged; Myocardial Infarction; Oleic Acid; Risk Factors; Time Factors; Vitamin B 6; Vitamin E | 2007 |
Effect of antioxidant-rich foods on plasma ascorbic acid, cardiac enzyme, and lipid peroxide levels in patients hospitalized with acute myocardial infarction.
Topics: Analysis of Variance; Ascorbic Acid; beta Carotene; Carotenoids; Diet, Fat-Restricted; Dietary Fiber; Female; Free Radicals; Humans; L-Lactate Dehydrogenase; Lipid Peroxides; Male; Myocardial Infarction; Single-Blind Method; Vitamin A; Vitamin E; Vitamins | 1995 |
Antioxidants in adipose tissue and risk of myocardial infarction.
Topics: Adipose Tissue; Aged; Carotenoids; Double-Blind Method; Humans; Insulin; Myocardial Infarction; Vitamin E | 1994 |
[Do antioxidants protect against myocardial infarct? Swiss contribution to the EURAMIC Study].
Topics: Adipose Tissue; Adult; Aged; Anthropometry; Antioxidants; beta Carotene; Carotenoids; Case-Control Studies; Humans; Life Style; Lipids; Male; Middle Aged; Myocardial Infarction; Vitamin E | 1994 |
[The biochemical, pharmacological and epidemiological reference picture of the GISSI-Prevention. The Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
Topics: Cholesterol; Fatty Acids, Omega-3; Female; Humans; Italy; Male; Myocardial Infarction; Streptokinase; Vitamin E | 1993 |
EURAMIC Study: antioxidants, myocardial infarction and breast cancer. Design and main hypotheses.
Topics: Aged; Antioxidants; beta Carotene; Breast Neoplasms; Carotenoids; Case-Control Studies; Europe; Female; Humans; Israel; Male; Middle Aged; Myocardial Infarction; Nutritional Physiological Phenomena; Research Design; Selenium; Vitamin E | 1993 |
Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3)
Topics: Adult; Antioxidants; Ascorbic Acid; Aspartate Aminotransferases; beta Carotene; Carotenoids; Creatine Kinase; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Humans; L-Lactate Dehydrogenase; Lipid Peroxides; Male; Middle Aged; Myocardial Infarction; Oxidative Stress; Ventricular Function, Left; Vitamin A; Vitamin E; Vitamins | 1996 |
Effects of antioxidant vitamins C and E on signal-averaged electrocardiogram in acute myocardial infarction.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; Drug Therapy, Combination; Electrocardiography; Female; Free Radicals; Humans; Leukocytes; Lipid Peroxides; Luminescent Measurements; Male; Middle Aged; Myocardial Infarction; Reactive Oxygen Species; Signal Processing, Computer-Assisted; Vitamin E | 1996 |
Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
Topics: Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Lipid Peroxidation; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Survival Analysis; Time Factors; Vitamin E | 1996 |
Supplementation with vitamins C and E suppresses leukocyte oxygen free radical production in patients with myocardial infarction.
Topics: Adult; Aged; Ascorbic Acid; Female; Humans; Lipid Peroxidation; Lipid Peroxides; Luminescent Measurements; Male; Middle Aged; Myocardial Infarction; Neutrophils; Vitamin E | 1995 |
Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction.
Topics: Aged; Antioxidants; beta Carotene; Coronary Disease; Double-Blind Method; Finland; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Placebos; Risk; Smoking; Vitamin E | 1997 |
High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men--a nested case-control study.
Topics: Aged; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Antibody Specificity; Autoantibodies; beta 2-Glycoprotein I; Bronchitis; Case-Control Studies; Cohort Studies; Comorbidity; Double-Blind Method; Glycoproteins; Humans; Lipoproteins, LDL; Lung Neoplasms; Male; Middle Aged; Myocardial Infarction; Prothrombin; Pulmonary Embolism; Risk; Risk Factors; Smoking; Thrombophilia; Thrombophlebitis; Vitamin E | 1997 |
Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease.
Topics: Aged; beta Carotene; Cardiovascular Agents; Coronary Disease; Dietary Supplements; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Risk; Treatment Outcome; Vitamin E | 1998 |
Effects of alpha tocopherol and beta carotene supplements on symptoms, progression, and prognosis of angina pectoris.
Topics: Aged; Angina Pectoris; beta Carotene; Coronary Disease; Double-Blind Method; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Prognosis; Recurrence; Smoking; Vitamin E | 1998 |
Cost-effectiveness of vitamin E therapy in the treatment of patients with angiographically proven coronary narrowing (CHAOS trial). Cambridge Heart Antioxidant Study.
Topics: Australia; Coronary Angiography; Coronary Disease; Cost Savings; Cost-Benefit Analysis; Health Care Costs; Humans; Myocardial Infarction; United States; Vitamin E | 1998 |
Tissue damage in acute myocardial infarction: selective protection by vitamin E.
Topics: Antioxidants; Electrocardiography; Female; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Solubility; Vitamin E | 1999 |
Alpha-tocopherol supplementation for men with existing coronary artery disease: a feasibility study.
Topics: Aged; Analysis of Variance; Antioxidants; Coronary Disease; Death, Sudden, Cardiac; Feasibility Studies; Follow-Up Studies; Humans; Lipids; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Recurrence; Thiobarbituric Acid Reactive Substances; Veterans; Vitamin E | 1999 |
Do vitamin E and fish oil protect against ischaemic heart disease?
Topics: Coronary Disease; Fish Oils; Humans; Myocardial Infarction; Recurrence; Vitamin E | 1999 |
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Fatty Acids, Omega-3; Female; Fish Oils; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Survival Rate; Treatment Outcome; Vitamin E | 1999 |
The state of lipid peroxidation and antioxidants following thrombolytic therapy with rt-PA and streptokinase in acute myocardial infarction.
Topics: Antioxidants; Ascorbic Acid; Fibrinolytic Agents; Free Radicals; Humans; Lipid Peroxidation; Lipid Peroxides; Malondialdehyde; Myocardial Infarction; Recombinant Proteins; Streptokinase; Thrombolytic Therapy; Tissue Plasminogen Activator; Ventricular Function, Left; Vitamin E | 1999 |
Vitamin E, a modifier of platelet function: rationale and use in cardiovascular and cerebrovascular disease.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Double-Blind Method; Hemorrhage; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Aggregation Inhibitors; Protein Kinase C; Recurrence; Time Factors; Vitamin E | 1999 |
Vitamin E supplementation and cardiovascular events in high-risk patients.
Topics: Aged; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Humans; Incidence; Male; Middle Aged; Mortality; Myocardial Infarction; Risk Factors; Stroke; Treatment Failure; Vitamin E | 2000 |
[ACE inhibitor even prevents diabetes. Sensational HOPE Study].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Myocardial Infarction; Ramipril; Stroke; Vitamin E | 1999 |
Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Diet; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Recurrence; Stroke; Vitamin E | 2001 |
Short term effect of atorvastatin and vitamin E on serum levels of C3, a sensitive marker of the risk of myocardial infarction in men.
Topics: Anticholesteremic Agents; Antioxidants; Atorvastatin; Biomarkers; Cholesterol, HDL; Complement C3c; Double-Blind Method; Drug Therapy, Combination; Heptanoic Acids; Humans; Male; Middle Aged; Myocardial Infarction; Pyrroles; Risk Factors; Vitamin E | 2001 |
[Effects of antioxidants and membrane protectors on clinical course and hemodynamics of patients with myocardial infarct].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Chloroquine; Female; Humans; Male; Middle Aged; Myocardial Infarction; Niacinamide; Vitamin E | 1992 |
[The effect of alpha-tocopherol on the hemodynamic indices of myocardial infarct patients].
Topics: Aged; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Vitamin E | 1989 |
169 other study(ies) available for d-alpha tocopherol and Cardiovascular Stroke
| Article | Year |
|---|---|
A cardioselective, hydrophilic N,N,N-trimethylethanaminium alpha-tocopherol analogue that reduces myocardial infarct size.
Topics: Animals; Benzopyrans; Brain; Cardiovascular Agents; Free Radical Scavengers; Indicators and Reagents; Lipid Peroxidation; Molecular Structure; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Structure-Activity Relationship; Tissue Distribution; Vitamin E | 1991 |
Pre-treatment with α-tocopherol and Terminalia arjuna ameliorates, pro-inflammatory cytokines, cardiac and apoptotic markers in myocardial infracted rats.
Topics: alpha-Tocopherol; Animals; Apoptosis; bcl-2-Associated X Protein; Cardiotonic Agents; Chromatography, Thin Layer; Cytokines; Inflammation; Isoproterenol; Lipid Peroxidation; Male; Muscle Cells; Myocardial Infarction; Oxidative Stress; Plant Extracts; Rats, Wistar; Terminalia | 2015 |
Cardioprotection with alpha-tocopheryl phosphate: amelioration of myocardial ischemia reperfusion injury is linked with its ability to generate a survival signal through Akt activation.
Topics: alpha-Tocopherol; Animals; Apoptosis; Blood Pressure; Blotting, Western; Cardiotonic Agents; Cell Survival; Coronary Circulation; DNA; Enzyme Activation; Heart Rate; Male; MAP Kinase Signaling System; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; NF-kappa B; Phosphorylation; Protein Binding; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Ventricular Function, Left | 2008 |
Preventive effect of S-allylcysteine on membrane-bound enzymes and glycoproteins in normal and isoproterenol-induced cardiac toxicity in male Wistar rats.
Topics: Adenosine Triphosphatases; alpha-Tocopherol; Animals; Antioxidants; Blood Proteins; Cell Membrane; Creatine Kinase, MB Form; Cysteine; Glycoproteins; Iron; Iron-Binding Proteins; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Uric Acid | 2008 |
SOD3 R231G polymorphism associated with coronary artery disease and myocardial infarction. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Topics: Aged; alpha-Tocopherol; Coronary Artery Disease; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Polymorphism, Genetic; Risk Factors; Superoxide Dismutase | 2009 |
Combined effects of quercetin and alpha-tocopherol on lipids and glycoprotein components in isoproterenol induced myocardial infarcted Wistar rats.
Topics: alpha-Tocopherol; Animals; Glycoproteins; Isoproterenol; Lipid Metabolism; Male; Myocardial Infarction; Quercetin; Rats; Rats, Wistar | 2009 |
Pretreatment with a combination of quercetin and alpha-tocopherol ameliorates adenosine triphosphatases and lysosomal enzymes in myocardial infarcted rats.
Topics: Adenosine Triphosphatases; alpha-Tocopherol; Animals; Antioxidants; Ca(2+) Mg(2+)-ATPase; Cell Membrane; Disease Models, Animal; Drug Therapy, Combination; Isoproterenol; Lipid Peroxidation; Lysosomes; Male; Myocardial Infarction; Myocardium; Pilot Projects; Quercetin; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase | 2010 |
Myocardial infarction risk in relation to zinc concentration in toenails.
Topics: Adipose Tissue; Aged; Aging; alpha-Tocopherol; Biomarkers; Case-Control Studies; Europe; Humans; Israel; Male; Middle Aged; Myocardial Infarction; Nails; Neutron Activation Analysis; Odds Ratio; Risk; Selenium; Toes; Zinc | 2003 |
Plasma carotenoids and tocopherols and risk of myocardial infarction in a low-risk population of US male physicians.
Topics: Adult; Aged; Aged, 80 and over; alpha-Tocopherol; beta Carotene; Carotenoids; Case-Control Studies; Comorbidity; Cryptoxanthins; Follow-Up Studies; gamma-Tocopherol; Humans; Lutein; Lycopene; Male; Middle Aged; Myocardial Infarction; Physicians; Prospective Studies; Risk; Risk Assessment; Smoking; Tocopherols; United States; Vitamin A; Xanthophylls | 2003 |
Antioxidant vitamin pool in senior population.
Topics: Aged; alpha-Tocopherol; Antioxidants; Ascorbic Acid; Chromatography, High Pressure Liquid; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Male; Myocardial Infarction | 2004 |
Comparative effects of Aegle marmelos extract and alpha-tocopherol on serum lipids, lipid peroxides and cardiac enzyme levels in rats with isoproterenol-induced myocardial infarction.
Topics: Adrenergic beta-Agonists; Aegle; alpha-Tocopherol; Animals; Antioxidants; Biomarkers; Female; Isoproterenol; Lipid Peroxides; Lipids; Myocardial Infarction; Phytotherapy; Plant Leaves; Rats; Rats, Wistar | 2005 |
Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment.
Topics: Adult; Aged; alpha-Tocopherol; Angina, Unstable; Angioplasty, Balloon, Coronary; Arginine; C-Reactive Protein; Cardiovascular Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Combined Modality Therapy; Coronary Angiography; Coronary Artery Disease; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Insulin; Lipoproteins, HDL; Male; Middle Aged; Myocardial Infarction; Statistics as Topic; Treatment Outcome; Triglycerides | 2005 |
S-allylcysteine ameliorates isoproterenol-induced cardiac toxicity in rats by stabilizing cardiac mitochondrial and lysosomal enzymes.
Topics: Adrenergic beta-Agonists; alpha-Tocopherol; Animals; Antineoplastic Agents; Cysteine; Electrocardiography; Heart Diseases; Isoproterenol; Lysosomes; Male; Mitochondria, Heart; Myocardial Infarction; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2007 |
Low plasma glutathione levels after reperfused acute myocardial infarction are associated with late cardiac events.
Topics: Aged; alpha-Tocopherol; Biomarkers; Confidence Intervals; Coronary Angiography; Dipeptides; Female; Follow-Up Studies; Glutathione; Humans; Luminescent Measurements; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Oxidation-Reduction; Prognosis; Proportional Hazards Models; Time Factors; Troponin T | 2007 |
Chronic administration of coenzyme Q10 limits postinfarct myocardial remodeling in rats.
Topics: alpha-Tocopherol; Animals; Cardiomegaly; Chromatography, High Pressure Liquid; Coenzymes; Male; Microscopy, Electron; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Ubiquinone; Ventricular Remodeling; Vitamins | 2007 |
[Effect of the antioxidant alpha-tocopherol acetate on organ-specific liver enzyme activity in acute myocardial infarct].
Topics: Acid Phosphatase; Adult; Aged; alpha-Tocopherol; Cholinesterases; Female; Fructose-Bisphosphate Aldolase; Glutamate Dehydrogenase; Humans; Lipid Peroxides; Liver; Male; Middle Aged; Myocardial Infarction; Organ Specificity; Tocopherols; Vitamin E | 1984 |
Antioxidant vitamin levels and glutathione peroxidase activity during ischemia/reperfusion in myocardial infarction.
Topics: Aged; alpha-Tocopherol; Antioxidants; beta Carotene; Female; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Oxidative Stress | 2001 |
Simultaneous determination of retinol, beta-carotene and alpha-tocopherol in adipose tissue by high-performance liquid chromatography.
Topics: Adipose Tissue; alpha-Tocopherol; beta Carotene; Chromatography, High Pressure Liquid; Diet; Humans; Myocardial Infarction; Portugal; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Surveys and Questionnaires; Vitamin A | 2001 |
Plasma status of retinol, alpha- and gamma-tocopherols, and main carotenoids to first myocardial infarction: case control and follow-up study.
Topics: Acute-Phase Reaction; alpha-Tocopherol; Antioxidants; Carotenoids; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Follow-Up Studies; gamma-Tocopherol; Humans; Life Style; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Spain; Vitamin A | 2002 |
[Dynamic changes in the histamine and serotonin levels of acute myocardial infarct patients treated with strepodecase, finoptin and alpha-tocopherol acetate].
Topics: Adult; Aged; alpha-Tocopherol; Drug Evaluation; Drug Therapy, Combination; Heparin; Histamine; Humans; Middle Aged; Myocardial Infarction; Serotonin; Streptokinase; Thrombolytic Therapy; Time Factors; Tocopherols; Verapamil; Vitamin E | 1992 |
[Phosphocreatine, tocopheryl phosphate and their combination in acute ischemia and myocardial reperfusion in dogs: the effect on rhythm disorders, left ventricle contractility and infarct size].
Topics: alpha-Tocopherol; Animals; Arrhythmias, Cardiac; Dogs; Drug Therapy, Combination; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphocreatine; Ventricular Function, Left; Vitamin E | 1991 |
Circulating Vitamin E Levels and Risk of Coronary Artery Disease and Myocardial Infarction: A Mendelian Randomization Study.
Topics: Adult; Aged; Cholesterol, LDL; Coronary Artery Disease; Female; Genome-Wide Association Study; Humans; Male; Mendelian Randomization Analysis; Middle Aged; Myocardial Infarction; Odds Ratio; Polymorphism, Single Nucleotide; Risk Factors; Triglycerides; Vitamin E | 2019 |
β-Cryptoxanthin exerts greater cardioprotective effects on cardiac ischemia-reperfusion injury than astaxanthin by attenuating mitochondrial dysfunction in mice.
Topics: Animals; Beta-Cryptoxanthin; Cardiotonic Agents; Disease Models, Animal; Heart; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mitochondrial Diseases; Myocardial Infarction; Myocardial Reperfusion Injury; Oxidative Stress; Reactive Oxygen Species; Thiobarbituric Acid Reactive Substances; Vitamin E; Xanthophylls | 2017 |
Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction.
Topics: Abietanes; Animals; Cell Death; Cell Survival; Drug Carriers; Drug Liberation; Endocytosis; Lipids; Molecular Targeted Therapy; Myocardial Infarction; Nanoparticles; Onium Compounds; Organophosphorus Compounds; Particle Size; Proton Magnetic Resonance Spectroscopy; Rats, Sprague-Dawley; Static Electricity; Tissue Distribution; Vitamin E | 2018 |
Plasma vitamin C, but not vitamin E, is associated with reduced risk of heart failure in older men.
Topics: Aged; Ascorbic Acid; Diabetic Angiopathies; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Assessment; Vitamin E | 2013 |
Antioxidant activity of ethanolic extract of Terminalia chebula fruit against isoproterenol-induced oxidative stress in rats.
Topics: Animals; Antioxidants; Ascorbic Acid; Ceruloplasmin; Ethanol; Fruit; Glutathione; Heart; Iron; Isoproterenol; Lipid Peroxidation; Male; Myocardial Infarction; Oxidation-Reduction; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Terminalia; Vitamin E | 2005 |
Ask the doctor. I had a heart attack 20 years ago. My doctor told me to stop taking vitamin E. My old cardiologist told me to take vitamin E every day to prevent another heart attack. What should I do?
Topics: Antioxidants; Attitude to Health; Contraindications; Health Status; Humans; Myocardial Infarction; Risk Reduction Behavior; Vitamin E | 2013 |
Protective effects of crocin on hemodynamic parameters and infarct size in comparison with vitamin E after ischemia reperfusion in isolated rat hearts.
Topics: Animals; Carotenoids; Dose-Response Relationship, Drug; Hemodynamics; In Vitro Techniques; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Vitamin E | 2014 |
Effects of vitamins C and E on the outcome after acute myocardial infarction in diabetics: a retrospective, hypothesis-generating analysis from the MIVIT study.
Topics: Aged; Antioxidants; Ascorbic Acid; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Oxidative Stress; Pilot Projects; Randomized Controlled Trials as Topic; Reactive Oxygen Species; Retrospective Studies; Risk Factors; Treatment Outcome; Vitamin E | 2009 |
Effect of green tea and vitamin E combination in isoproterenol induced myocardial infarction in rats.
Topics: Adenosine Triphosphatases; Analysis of Variance; Animals; Antioxidants; Drug Synergism; Isoproterenol; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; Organ Size; Oxidative Stress; Plant Extracts; Random Allocation; Rats; Rats, Wistar; Tea; Vitamin E; Weight Gain | 2009 |
Effect of acute myocardial infarction on erythrocytic glutathione peroxidase 1 activity and plasma vitamin e levels.
Topics: Aged; Case-Control Studies; Erythrocytes; Female; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Taiwan; Vitamin E | 2009 |
Effects of nitric oxide donor antioxidants containing the phenol vitamin E substructure and a furoxan moiety on ischemia/reperfusion injury.
Topics: Animals; Antioxidants; Buffers; In Vitro Techniques; Indicators and Reagents; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide Donors; Nitroblue Tetrazolium; Oxadiazoles; Rats; Rats, Wistar; Reperfusion Injury; Vasodilator Agents; Vitamin E | 2009 |
Protective effect of tomato against adrenaline-induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Aspartate Aminotransferases; Carotenoids; Epinephrine; Female; Free Radical Scavengers; Lipid Peroxidation; Lycopene; Male; Malondialdehyde; Myocardial Infarction; Myocardium; Necrosis; Plant Extracts; Random Allocation; Rats; Solanum lycopersicum; Vitamin E | 2008 |
Co-ordinated autophagy with resveratrol and γ-tocotrienol confers synergetic cardioprotection.
Topics: Animals; Antioxidants; Apoptosis; Autophagy; Cardiotonic Agents; Chromans; Drug Synergism; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Signal Transduction; Stilbenes; Vitamin E | 2010 |
Cardiac biomarkers in a model of acute catecholamine cardiotoxicity.
Topics: Animals; Antioxidants; Ascorbic Acid; Biomarkers; Blood Pressure; Calcium; Catecholamines; Disease Models, Animal; Heart Function Tests; Heart Rate; Heart Ventricles; Iron; Isoproterenol; Male; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Wistar; Reactive Oxygen Species; Troponin T; Vitamin E; Zinc | 2009 |
Protective effect of caffeic acid on cardiac markers and lipid peroxide metabolism in cardiotoxic rats: an in vivo and in vitro study.
Topics: Animals; Ascorbic Acid; Biomarkers; Caffeic Acids; Isoproterenol; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Uric Acid; Vitamin E | 2010 |
Protective effect of sesamol against myocardial infarction caused by isoproterenol in Wistar rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Ascorbic Acid; Aspartate Aminotransferases; Benzodioxoles; Creatine Kinase; Glutathione; Isoproterenol; L-Lactate Dehydrogenase; Lipid Peroxides; Male; Myocardial Infarction; Myocardium; Phenols; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Troponin I; Troponin T; Vitamin E | 2010 |
Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype.
Topics: Antioxidants; Cardiovascular Diseases; Diabetes Mellitus; Genotype; Haptoglobins; Humans; Myocardial Infarction; Stroke; Tocopherols; Vitamin E | 2010 |
How to avoid a heart attack: putting it all together.
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Humans; Myocardial Infarction; Vitamin B Complex; Vitamin E | 2010 |
Oxidative stress versus antioxidant defenses in patients with acute myocardial infarction.
Topics: Adult; Antioxidants; Ascorbic Acid; Biomarkers; Brazil; Case-Control Studies; Catalase; Female; Humans; Lipid Peroxidation; Male; Middle Aged; Myocardial Infarction; Oxidative Stress; Protein Carbonylation; Reactive Oxygen Species; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Troponin I; Vitamin E | 2011 |
Comments on Vennila and Pugalendi. Vennila L, Pugalendi KV. Protective effect of sesamol against myocardial infarction caused by isoproterenol in Wistar rats. Redox Rep 2010; 15: 36-42.
Topics: Alanine Transaminase; Animals; Antioxidants; Ascorbic Acid; Aspartate Aminotransferases; Benzodioxoles; Creatine Kinase; Glutathione; Isoproterenol; L-Lactate Dehydrogenase; Lipid Peroxides; Male; Myocardial Infarction; Phenols; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Troponin I; Troponin T; Vitamin E | 2010 |
Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation.
Topics: Aspirin; Atrial Fibrillation; Cause of Death; Female; Follow-Up Studies; Health Personnel; Heart Failure; Humans; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Stroke; United States; Vitamin E; Vitamins | 2011 |
Plasma vitamin E and coenzyme Q10 are not associated with a lower risk of acute myocardial infarction in Singapore Chinese adults.
Topics: Aged; Asian People; Case-Control Studies; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Singapore; Ubiquinone; Vitamin E | 2012 |
Vitamin E attenuates myocardial ischemia-reperfusion injury in murine AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adenosine Diphosphate; Animals; Antioxidants; CD11b Antigen; Disease Models, Animal; Female; Heart Ventricles; Mice; Mice, Inbred C57BL; Models, Cardiovascular; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; P-Selectin; Platelet Aggregation; Reactive Oxygen Species; Risk Factors; Vitamin E | 2002 |
[Results of GISSI Prevenzione: diet, drugs, and cardiovascular risk. Researchers of GISSI Prevenzione].
Topics: Cardiovascular Diseases; Diet; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk Factors; Triglycerides; Vitamin E | 1999 |
Alcoholic beverage preference and characteristics of drinkers and nondrinkers in western New York (United States).
Topics: Adult; Aged; Alcohol Drinking; Alcoholic Beverages; Beer; Breast Neoplasms; Carotenoids; Case-Control Studies; Diet; Dietary Fats; Dietary Fiber; Edible Grain; Educational Status; Female; Food Preferences; Fruit; Humans; Income; Life Style; Lung Neoplasms; Male; Middle Aged; Myocardial Infarction; New York; Potassium, Dietary; Prostatic Neoplasms; Smoking; Vegetables; Vitamin E; Wine | 2003 |
High-volume hospitals and surgeons still safest.
Topics: Carotenoids; Coronary Artery Bypass; Hospitalization; Hospitals; Humans; Male; Myocardial Infarction; Risk Adjustment; Treatment Failure; Vitamin E | 2003 |
[Therapy of myocardial infarct].
Topics: Adenosine Triphosphate; Ascorbic Acid; Bile Acids and Salts; Coumarins; Diet; Folic Acid; Heparin; Humans; Hypnotics and Sedatives; Khellin; Magnesium Sulfate; Myocardial Infarction; Purines; Quinidine; Salts; Sympathomimetics; Vitamin B Complex; Vitamin E; Vitamins | 1953 |
A means of lowering elevated blood cholesterol levels in patients with previous myocardial infarction.
Topics: Cardiovascular Diseases; Cholesterol; Fatty Acids; Humans; Myocardial Infarction; Steroids; Vitamin B 6; Vitamin E | 1958 |
PLASMA VITAMIN A AND E IN THE STUDY OF LIPID AND LIPOPROTEIN METABOLISM IN CORONARY HEART DISEASE.
Topics: Blood; Cholesterol; Coronary Disease; Glycerides; Humans; Lipid Metabolism; Lipids; Lipoproteins; Myocardial Infarction; Statistics as Topic; Vitamin A; Vitamin E | 1963 |
THERAPEUTIC RESULTS WITH LINOSCLERIN AFTER MYOCARDIAL INFARCTION IN MEN.
Topics: Cholesterol; Fatty Acids; Fatty Acids, Essential; Heart Function Tests; Humans; Lipids; Lipoproteins; Male; Myocardial Infarction; Phospholipids; Pyridoxine; Vitamin E | 1963 |
THE EFFECTS OF VITAMIN E IN RATS KEPT ON A CARDIOPATHOGENIC DIET.
Topics: Arteriosclerosis; Aspartate Aminotransferases; Cholesterol; Diet; Myocardial Infarction; Myocardium; Pharmacology; Phosphoric Monoester Hydrolases; Rats; Research; Vitamin E | 1963 |
VITAMIN A, TOCOPHEROL AND SERUMCHOLESTEROL IN PATIENTS WITH ANGINA PECTORIS.
Topics: Angina Pectoris; Blood Chemical Analysis; Cholesterol; Geriatrics; Myocardial Infarction; Tocopherols; Vitamin A; Vitamin E | 1963 |
Dietary fiber reduces peripheral arterial disease risk in men.
Topics: Adult; Aged; Arterial Occlusive Diseases; Ascorbic Acid; Body Mass Index; Boston; Dietary Fiber; Dietary Supplements; Feeding Behavior; Humans; Male; Middle Aged; Myocardial Infarction; Patient Selection; Reproducibility of Results; Risk Factors; Smoking; Surveys and Questionnaires; Vitamin E | 2003 |
Mechanisms of cardioprotective effect of Withania somnifera in experimentally induced myocardial infarction.
Topics: Administration, Oral; Animals; Antioxidants; Male; Myocardial Infarction; Myocardium; Plant Extracts; Plant Roots; Rats; Rats, Wistar; Ventricular Function, Left; Ventricular Pressure; Vitamin E; Withania | 2004 |
Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment.
Topics: Animals; Blood Pressure; Catalase; Creatine Kinase; Female; Glutathione; Glutathione Peroxidase; Heart Rate; Isoproterenol; Male; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Myocardium; Necrosis; Phytotherapy; Plant Extracts; Plant Roots; Rats; Rats, Wistar; Reperfusion Injury; Superoxide Dismutase; Ventricular Pressure; Vitamin E; Withania | 2004 |
Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Angioplasty, Balloon, Laser-Assisted; Antioxidants; Biomarkers; C-Reactive Protein; Coronary Angiography; Dinoprost; Female; Humans; Male; Middle Aged; Myocardial Infarction; Oxidative Stress; Troponin T; Vitamin A; Vitamin E | 2004 |
Depletion of antioxidants is associated with no-reflow phenomenon in acute myocardial infarction.
Topics: Aged; Aged, 80 and over; Antioxidants; Ascorbic Acid; beta Carotene; Catalase; Coronary Circulation; Female; Glutathione Peroxidase; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Oxidation-Reduction; Statistics, Nonparametric; Superoxide Dismutase; Vitamin E | 2004 |
Oxidative stress and antioxidants in patients with cardiogenic shock complicating acute myocardial infarction.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Blood Pressure; Catalase; Female; Glutathione; Glutathione Peroxidase; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Oxidative Stress; Shock, Cardiogenic; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vitamin E | 2004 |
Isoproterenol-induced myocardial infarction in rabbits. Protection by propranolol or labetalol: a proposed non-invasive procedure.
Topics: Adrenergic beta-Antagonists; Animals; Electrocardiography; Isoproterenol; Labetalol; Lipid Peroxides; Male; Myocardial Infarction; Myocardium; Partial Thromboplastin Time; Propranolol; Rabbits; Vitamin E | 2004 |
Antioxidant vitamin levels do not exhibit negative correlation with the extent of acute myocardial infarction.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Female; Humans; Male; Middle Aged; Myocardial Infarction; Vitamin E; Vitamins | 2005 |
Vitamin E-gads.
Topics: Controlled Clinical Trials as Topic; Double-Blind Method; Heart Failure; Humans; Myocardial Infarction; Placebos; Stroke; United States; Vitamin E | 2005 |
Bid farewell to an old but unhelpful friend. It's time to face the facts: vitamin E won't protect you from a heart attack or stroke.
Topics: Antioxidants; Humans; Mortality; Myocardial Infarction; Stroke; Treatment Failure; Vitamin E | 2005 |
Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial.
Topics: Antioxidants; Fatty Acids, Omega-3; Female; Follow-Up Studies; Heart Failure; Humans; Incidence; Italy; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Vitamin E | 2006 |
Vitamins C and E attenuate apoptosis, beta-adrenergic receptor desensitization, and sarcoplasmic reticular Ca2+ ATPase downregulation after myocardial infarction.
Topics: Animals; Apoptosis; Ascorbic Acid; Blotting, Western; Calcium-Transporting ATPases; Down-Regulation; Echocardiography; Heart Failure; Immunohistochemistry; In Situ Nick-End Labeling; Male; Mitochondria; Muscle Cells; Myocardial Infarction; Oxidative Stress; Rabbits; Receptors, Adrenergic, beta; Sarcoplasmic Reticulum; Ventricular Remodeling; Vitamin E; Vitamins | 2006 |
Does vitamin E help prevent heart disease or heart attack?
Topics: Cardiovascular Diseases; Female; Hemorrhage; Humans; Myocardial Infarction; Vitamin E; Vitamins | 2006 |
Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial.
Topics: Diabetes Mellitus; Dietary Supplements; Fatty Acids, Omega-3; Humans; Hypertension; Myocardial Infarction; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke Volume; Ventricular Premature Complexes; Vitamin E; Vitamins | 2007 |
The combined role of atheroma, cholesterol, platelets, the endothelium and fibrin in heart attacks and strokes.
Topics: Animals; Arteriosclerosis; Blood Platelets; Blood Vessels; Cerebral Infarction; Cholesterol; Dietary Fats; Endothelium; Fibrinolysis; Humans; Linoleic Acids; Lipid Peroxides; Margarine; Myocardial Infarction; Prostaglandins; Stereoisomerism; Vitamin E | 1984 |
[Effect of vitamins A and E on the contractile function of the heart in experimental myocardial infarction].
Topics: Animals; Cell Membrane Permeability; Dose-Response Relationship, Drug; Lysosomes; Microscopy, Electron; Myocardial Contraction; Myocardial Infarction; Myocardium; Rabbits; Vitamin A; Vitamin E | 1983 |
[Correction of disturbances of the relation between the levels of lipids and the products of their peroxidation in patients with coronary atherosclerosis and myocardial infarction].
Topics: Antioxidants; Cholesterol; Coronary Disease; Fatty Acids, Unsaturated; Humans; Lipid Peroxides; Lipids; Myocardial Infarction; Phospholipids; Vitamin A; Vitamin E | 1982 |
[Aging and lipid peroxides (author's transl)].
Topics: Adult; Aged; Aging; Animals; Arteriosclerosis; Blood Platelets; Brain Chemistry; Guinea Pigs; Humans; Lipid Peroxides; Lipofuscin; Middle Aged; Myocardial Infarction; Prostaglandins; Rabbits; Vitamin E | 1981 |
Effects of vitamin E on endothelial function in men after myocardial infarction.
Topics: Acetylcholine; Antioxidants; Blood Flow Velocity; Dose-Response Relationship, Drug; Endothelium, Vascular; Forearm; Humans; Male; Middle Aged; Myocardial Infarction; Nitroprusside; Time Factors; Vitamin E | 1995 |
Do antioxidant vitamins reduce infarct size following acute myocardial ischemia/reperfusion?
Topics: Animals; Antioxidants; Ascorbic Acid; Blood Pressure; Chromans; Disease Models, Animal; Drug Therapy, Combination; Free Radical Scavengers; Heart Rate; Hydrogen-Ion Concentration; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Rabbits; Random Allocation; Staining and Labeling; Tetrazolium Salts; Vitamin E | 1995 |
Vitamin E can protect myocardium against oxidative damage.
Topics: Animals; Free Radical Scavengers; Free Radicals; Humans; Lipid Peroxidation; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rabbits; Vitamin E | 1995 |
Epidemiological feasibility of cardiovascular primary prevention in general practice: a trial of vitamin E and aspirin. Collaborative group of the Primary Prevention Project.
Topics: Aged; Arteriosclerosis; Aspirin; Cardiovascular Diseases; Clinical Protocols; Contraindications; Diabetes Complications; Disease Progression; Epidemiologic Methods; Family Practice; Feasibility Studies; Female; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Myocardial Infarction; Obesity; Patient Selection; Primary Prevention; Risk Factors; Thrombosis; Vitamin E | 1995 |
Plasma levels of antioxidant vitamins and oxidative stress in patients with acute myocardial infarction.
Topics: Antioxidants; Arrhythmias, Cardiac; Ascorbic Acid; beta Carotene; Carotenoids; Case-Control Studies; Female; Humans; Lipid Peroxides; Male; Middle Aged; Myocardial Infarction; Oxidative Stress; Prospective Studies; Vitamin A; Vitamin E; Vitamins | 1994 |
Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC Study.
Topics: Adipose Tissue; Adult; Aged; Antioxidants; beta Carotene; Carotenoids; Case-Control Studies; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Risk Factors; Vitamin E | 1993 |
Antioxidants in adipose tissue and risk of myocardial infarction.
Topics: Adipose Tissue; Carotenoids; Confounding Factors, Epidemiologic; Humans; Myocardial Infarction; Odds Ratio; Risk Factors; Smoking; Vitamin E | 1994 |
Effects of dietary supplementation with alpha-tocopherol on myocardial infarct size and ventricular arrhythmias in a dog model of ischemia-reperfusion.
Topics: Animals; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Food, Fortified; Hemodynamics; Myocardial Infarction; Myocardial Reperfusion Injury; Random Allocation; Tachycardia, Ventricular; Vitamin E | 1994 |
Oxidized low-density lipoproteins and endothelium: oral vitamin E supplementation prevents oxidized low-density lipoprotein-mediated vascular injury.
Topics: Administration, Oral; Adult; Animals; Ascorbic Acid; Cells, Cultured; Drug Interactions; Endothelium, Vascular; Female; Heme; Humans; Hydrogen Peroxide; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Oxidation-Reduction; Swine; Vitamin E | 1993 |
Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction?
Topics: Adult; Aged; Carotenoids; Case-Control Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Regression Analysis; Risk Factors; Smoking; Vitamin E | 1994 |
Lack of an association between serum vitamin E and myocardial infarction in a population with high vitamin E levels.
Topics: Adult; Alcohol Drinking; Antioxidants; Case-Control Studies; Cholesterol; Cholesterol, HDL; Female; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Smoking; Vitamin E | 1993 |
Antioxidants and risk of myocardial infarction. EURAMIC Study Group.
Topics: Adipose Tissue; Adult; Aged; beta Carotene; Body Weight; Carotenoids; Chromatography, High Pressure Liquid; Humans; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Risk Factors; Smoking; Vitamin E | 1993 |
Lipid peroxidation and antioxidant status following thrombolytic therapy for acute myocardial infarction.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; Chromatography, High Pressure Liquid; Coronary Circulation; Female; Free Radicals; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator; Vascular Patency; Vitamin E | 1993 |
Failure of chronic, high-dose, oral vitamin E treatment to protect the ischemic, reperfused porcine heart.
Topics: Administration, Oral; Animals; Diastole; Female; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Swine; Systole; Vitamin E | 1993 |
Protection of infarcted, chronically reperfused hearts by an alpha-tocopherol analogue.
Topics: Animals; Cardiovascular Agents; Catecholamines; Coronary Circulation; Creatine Kinase; Epinephrine; Free Radical Scavengers; In Vitro Techniques; Lipid Peroxidation; Lipid Peroxides; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Norepinephrine; Rats; Rats, Sprague-Dawley; Vitamin E | 1993 |
Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats.
Topics: Animals; Catalase; Glutathione; Glutathione Peroxidase; Heart Failure; Hemodynamics; Lipid Peroxidation; Male; Myocardial Infarction; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Vitamin E | 1996 |
Decreased free radical scavengers with reperfusion after coronary angioplasty in patients with acute myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Erythrocytes; Female; Free Radical Scavengers; Free Radicals; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Prospective Studies; Reactive Oxygen Species; Selenium; Superoxide Dismutase; Time Factors; Ventricular Function, Left; Vitamin E | 1996 |
Assessment of radical activity during the acute phase of myocardial infarction following fibrinolysis: utility of assaying plasma malondialdehyde.
Topics: Aged; beta Carotene; Carotenoids; Chromatography, High Pressure Liquid; Female; Fibrinolysis; Free Radicals; Glutathione Peroxidase; Humans; Kinetics; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Myosins; Thiobarbituric Acid Reactive Substances; Thrombolytic Therapy; Uric Acid; Vitamin E | 1995 |
Inverse relation between the concentration of low-density-lipoprotein vitamin E and severity of coronary artery disease.
Topics: Adult; Cholesterol; Coronary Angiography; Coronary Disease; Humans; Lipid Peroxidation; Lipoproteins, LDL; Male; Myocardial Infarction; Plasma; Triglycerides; Vitamin E | 1996 |
Vitamin E and coronary heart disease.
Topics: Arteriosclerosis; Food, Organic; Humans; Myocardial Infarction; Vitamin E | 1996 |
Vitamin E and coronary heart disease.
Topics: Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Stunning; Vitamin E | 1996 |
[Vitamin E treatment of patients with coronary disease (Cambridge Heart Antioxidant Study--CHAOS)].
Topics: Coronary Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Randomized Controlled Trials as Topic; Time Factors; Vitamin E | 1996 |
Aspirin, vitamin E and heart attack prevention.
Topics: Aspirin; Humans; Myocardial Infarction; Vitamin E | 1996 |
Serum levels of vitamin E in relation to cardiovascular diseases.
Topics: Adult; Aged; Arteriosclerosis; Female; Heart Diseases; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Vascular Diseases; Vitamin E | 1995 |
The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men: 19 years follow-up.
Topics: Biomarkers; Blood Pressure; Cholesterol Esters; Chromatography, High Pressure Liquid; Electrocardiography; Fatty Acids; Follow-Up Studies; Health Surveys; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Radioimmunoassay; Regression Analysis; Retrospective Studies; Risk Factors; Triglycerides; Vitamin E | 1996 |
Effect of alpha-tocopherol on isoproterenol induced myocardial infarction in rats--electrocardiographic biochemical and histological evidences.
Topics: Animals; Aorta; Cardiotonic Agents; Drug Interactions; Electrocardiography; Heart Rate; Isoproterenol; Lipid Peroxidation; Lipid Peroxides; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Vitamin E | 1996 |
Inhibitory effects of a phosphate diester of alpha-tocopherol and ascorbic acid (EPC-K1) on myocardial infarction in rats.
Topics: Animals; Antioxidants; Ascorbic Acid; Benzoquinones; Free Radical Scavengers; Lipoxygenase Inhibitors; Lysosomes; Male; Myocardial Infarction; Peroxidase; Rats; Rats, Sprague-Dawley; Superoxides; Vitamin E | 1996 |
Antioxidants to treat coronary artery disease.
Topics: Antioxidants; Coronary Disease; Humans; Myocardial Infarction; Vitamin E | 1997 |
Receptor density in the rat heart following ischaemia and prolonged reperfusion.
Topics: Animals; Autoradiography; Free Radical Scavengers; Heart Ventricles; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rats; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Vitamin E | 1995 |
[Free radicals and antioxidants].
Topics: Antioxidants; Humans; Myocardial Infarction; Reactive Oxygen Species; Vitamin E | 1997 |
Acetylsalicylic acid and vitamin E in prevention of arterial thrombosis.
Topics: Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Drug Interactions; Humans; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Thrombosis; Vitamin E | 1997 |
Anti-oxidant therapy for ischaemic heart disease: where do we stand?
Topics: Antioxidants; beta Carotene; Coronary Artery Disease; Humans; Lipid Peroxidation; Myocardial Infarction; Myocardial Ischemia; Smoking; Vitamin E | 1997 |
Antioxidants and ischaemic heart disease.
Topics: Antioxidants; beta Carotene; Coronary Disease; Evidence-Based Medicine; Humans; Lipoproteins, LDL; Myocardial Infarction; Vitamin E | 1997 |
[Plasma levels of vitamins A and E and the risk of acute myocardial infarct].
Topics: Adult; Aged; Case-Control Studies; Confidence Intervals; Humans; Middle Aged; Myocardial Infarction; Odds Ratio; Risk Factors; Spain; Time Factors; Urban Population; Vitamin A; Vitamin E | 1997 |
Interventional therapy with megadose of antioxidant vitamins in patients with acute myocardial infarction: could we throw caution to the winds?
Topics: Animals; Antioxidants; Ascorbic Acid; Dose-Response Relationship, Drug; Drug Interactions; Humans; Myocardial Infarction; Vitamin A; Vitamin E | 1997 |
Antioxidant activity of U-83836E, a second generation lazaroid, during myocardial ischemia/reperfusion injury.
Topics: Aldehydes; Animals; Antioxidants; Cardiovascular System; Chromans; Free Radical Scavengers; Hydroxyl Radical; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Pancreatic Elastase; Piperazines; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Vitamin E | 1997 |
[The impact of the intravenous He-Ne laser therapy on the antioxidant system in patient with stable exertion angina and postinfarct cardiosclerosis].
Topics: Adult; Angina Pectoris; Angioplasty, Balloon, Laser-Assisted; Ascorbic Acid; Catalase; Ceruloplasmin; Female; Helium; Humans; Isotopes; Male; Middle Aged; Myocardial Infarction; Myocardium; Neon; Physical Exertion; Sclerosis; Vitamin A; Vitamin E | 1997 |
The lipid peroxidation inhibitor indenoindole H290/51 protects myocardium at risk of injury induced by ischemia-reperfusion.
Topics: Animals; Antioxidants; Drug Evaluation, Preclinical; Female; Free Radicals; Hemodynamics; Indoles; Lipid Peroxidation; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Risk Factors; Swine; Ventricular Function, Left; Vitamin E | 1998 |
Effect of EPC-K1 on myocardial infarct size in a rat model with coronary artery occlusion and reperfusion.
Topics: Animals; Antioxidants; Arterial Occlusive Diseases; Ascorbic Acid; Combined Modality Therapy; Coronary Disease; Disease Models, Animal; Free Radical Scavengers; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Vitamin E | 1998 |
Antioxidative defense in human myocardial reperfusion injury.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; Catalase; Erythrocytes; Glutathione Peroxidase; Glutathione Reductase; Humans; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Superoxide Dismutase; Thrombolytic Therapy; Vitamin E | 1998 |
Beneficial effect of raxofelast, an hydrophilic vitamin E analogue, in the rat heart after ischemia and reperfusion injury.
Topics: Alkenes; Animals; Antioxidants; Benzofurans; Glutathione; Hemodynamics; Male; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Peroxidase; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Vitamin E | 1998 |
Effect of alpha-tocopherol on mitochondrial electron transport in experimental myocardial infarction in rats.
Topics: Animals; Citric Acid Cycle; Cytochromes; Electron Transport; Isoproterenol; Lipid Peroxidation; Lipid Peroxides; Male; Mitochondria, Heart; Myocardial Infarction; Rats; Rats, Wistar; Reference Values; Vitamin E | 1998 |
Differences between plasma and adipose tissue biomarkers of carotenoids and tocopherols.
Topics: Adipose Tissue; Aged; Biomarkers; Carotenoids; Female; Global Health; Humans; Male; Middle Aged; Myocardial Infarction; Nutritional Status; Odds Ratio; Predictive Value of Tests; Sex Factors; Vitamin E | 1998 |
Mortality in the CHAOS trial.
Topics: Clinical Trials as Topic; Coronary Artery Disease; Double-Blind Method; Humans; Myocardial Infarction; Myocardial Ischemia; Vitamin E | 1999 |
Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study.
Topics: Aged; Aged, 80 and over; Antioxidants; Ascorbic Acid; beta Carotene; Diet; Female; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Regression Analysis; Risk Factors; Smoking; Surveys and Questionnaires; Vitamin E | 1999 |
Effect of alpha-tocopherol pretreatment on infarct size following 90 minutes of ischemia and 4 hours of reperfusion in dogs.
Topics: Animals; Antioxidants; Dogs; Free Radicals; Heart; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; Reperfusion Injury; Vitamin E | 1997 |
Effect of alpha-tocopherol on lipid peroxidation in isoproterenol induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Free Radicals; Isoproterenol; Lipid Peroxidation; Male; Myocardial Infarction; Oxidoreductases; Rats; Rats, Wistar; Vitamin E | 1997 |
Mortality in the CHAOS trial. Cambridge Heart Antioxidant Study.
Topics: Antioxidants; Coronary Artery Disease; Follow-Up Studies; Humans; Myocardial Infarction; Placebos; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate; Treatment Outcome; Vitamin E | 1999 |
GISSI-Prevenzione trial.
Topics: Fatty Acids, Omega-3; Humans; Myocardial Infarction; Vitamin E | 1999 |
GISSI-Prevenzione trial.
Topics: Humans; Myocardial Infarction; Vitamin E | 1999 |
GISSI-Prevenzione trial.
Topics: Fatty Acids, Omega-3; Humans; Myocardial Infarction; Vitamin E | 1999 |
Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Arteriosclerosis; Coronary Artery Bypass; Coronary Disease; Dietary Fats, Unsaturated; Female; Humans; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Risk Factors; Vitamin E | 2000 |
Beneficial effects of vitamin E treatment in acute myocardial infarction.
Topics: Animals; Antioxidants; Electrocardiography; Hemodynamics; Male; Myocardial Infarction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Vitamin E | 2000 |
A study of lipid peroxide and alpha tocopherol in acute myocardial infarction.
Topics: Adult; Aged; Electrocardiography; Female; Fibrinolytic Agents; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Prospective Studies; Streptokinase; Vitamin E | 1999 |
Do fish oils or vitamin E reduce morbidity and mortality after myocardial infarction?
Topics: Aged; Animals; Dietary Supplements; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Fish Oils; Humans; Italy; Male; Middle Aged; Mortality; Myocardial Infarction; Randomized Controlled Trials as Topic; Reproducibility of Results; Stroke; Treatment Outcome; Vitamin E | 1999 |
Susceptibility of apolipoprotein B-containing lipoproteins to oxidation and antioxidant status in acute coronary syndromes.
Topics: Aged; Angina Pectoris; Angina, Unstable; Apolipoproteins B; Carotenoids; Cholesterol, LDL; Cholesterol, VLDL; Chronic Disease; Coronary Disease; Female; Humans; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Oxidation-Reduction; Time Factors; Vitamin E | 2000 |
Relationship of oxidative stress indices to decreased LDL-cholesterol after acute myocardial infarction.
Topics: Adult; Aged; Antioxidants; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Humans; Lipid Peroxides; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Oxidative Stress; Peroxides; Pilot Projects; Time Factors; Vitamin E | 2000 |
Effect of smoking on lipid profile, lipid peroxidation and antioxidant status in normal subjects and in patients during and after acute myocardial infarction.
Topics: Adult; Aged; Antioxidants; Body Mass Index; Cholesterol; Female; Humans; Lipid Peroxidation; Lipids; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Smoking; Vitamin E | 2000 |
A pilot study of streptokinase-induced endothelial injury and platelet activation following acute myocardial infarction.
Topics: Aged; Analysis of Variance; Case-Control Studies; Endothelium, Vascular; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Oxidative Stress; P-Selectin; Pilot Projects; Platelet Activation; Prospective Studies; Streptokinase; Thrombomodulin; Vitamin E; von Willebrand Factor | 2000 |
Intake of flavonols and flavones and risk of coronary heart disease in male smokers.
Topics: Aged; Antioxidants; beta Carotene; Cohort Studies; Double-Blind Method; Finland; Flavonoids; Flavonols; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Smoking; Vitamin E | 2001 |
Lipid peroxidation and vitamin E in ischemic heart disease.
Topics: Coronary Disease; Female; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Vitamin E | 1997 |
Magnesium deficiency potentiates free radical production associated with myocardial infarction.
Topics: Aged; Female; Free Radicals; Glutathione; Humans; Magnesium; Magnesium Deficiency; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Reactive Oxygen Species; Risk Factors; Vitamin E | 2000 |
Oxidative stress after acute myocardial infarction: effect of thrombolytic treatment.
Topics: Aged; Cholesterol; Female; Free Radicals; Humans; Lipid Peroxidation; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Oxidative Stress; Streptokinase; Thiobarbituric Acid Reactive Substances; Thrombolytic Therapy; Vitamin E | 2000 |
Vitamin E and lipid peroxide plasma levels predict the risk of cardiovascular events in a group of healthy very old people.
Topics: Age Distribution; Age Factors; Aged; Aged, 80 and over; Ascorbic Acid; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Heart Failure; Humans; Incidence; Italy; Lipid Peroxides; Longitudinal Studies; Male; Multivariate Analysis; Myocardial Infarction; Oxidative Stress; Predictive Value of Tests; Risk Factors; Stroke; Triglycerides; Vitamin E | 2001 |
Therapy and clinical trials.
Topics: Cell Cycle Proteins; Clinical Trials as Topic; Female; Hormone Replacement Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Myocardial Infarction; Peptide Elongation Factor 1; Point Mutation; Proteins; Prothrombin; Vitamin E | 2001 |
[Primary prevention of cardiovascular events by ASS and vitamin E. PPP--Primary Prevention Project].
Topics: Antioxidants; Aspirin; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Stroke; Treatment Outcome; Vitamin E | 2001 |
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Canada; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Comorbidity; Cyclooxygenase Inhibitors; Death, Sudden, Cardiac; Demography; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Odds Ratio; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Thromboxane B2; Thromboxanes; Vitamin E | 2002 |
[Free-radical lipid oxidation in the pathogenesis of myocardial infarct and the therapeutic and prophylactic role of antioxidants, sodium selenite and its combination with vitamin E].
Topics: Animals; Antioxidants; Drug Combinations; Free Radicals; Lipid Metabolism; Luminescent Measurements; Male; Myocardial Infarction; Myocardium; Oxidation-Reduction; Rats; Selenium; Vitamin E | 1978 |
[New ways in the therapy of myocardial infarction? Use of naturally existing chemicals].
Topics: Animals; Magnesium; Myocardial Infarction; Selenium; Vitamin E; Zinc | 1978 |
[Morphologic indices the influence of selenium and vitamin E on the course of experimental myocardial infarct].
Topics: Animals; Granulation Tissue; Histocytochemistry; L-Lactate Dehydrogenase; Male; Microscopy, Electron; Myocardial Infarction; Myocardium; Rats; Selenium; Succinate Dehydrogenase; Vitamin E | 1976 |
Protective effects of an alpha-tocopherol analogue against myocardial reperfusion injury in rats.
Topics: Animals; Cardioplegic Solutions; Cardiovascular Agents; Coronary Disease; Free Radical Scavengers; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Inbred Strains; Vitamin E | 1992 |
Examination of two small-molecule antiperoxidative agents in a rabbit model of postischemic myocardial infarction.
Topics: Animals; Antioxidants; Coronary Disease; Heart; Hemodynamics; Myocardial Infarction; Myocardium; Necrosis; Organ Size; Rabbits; Random Allocation; Vitamin E | 1991 |
Reduction of experimental myocardial infarct size by oral administration of alpha tocopherol.
Topics: Administration, Oral; Animals; Male; Myocardial Infarction; Rabbits; Vitamin E | 1991 |
[Clinical course and necrotic area size in patients with myocardial infarct receiving combined treatment including antioxidants and membrane-protecting agents].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Niacinamide; Time Factors; Vitamin E | 1991 |
U74006F, a novel 21-aminosteroid, inhibits in vivo lipid peroxidation but fails to limit infarct size in a canine model of myocardial ischemia reperfusion.
Topics: Animals; Dogs; Hemodynamics; Leukocyte Count; Lipid Peroxides; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Pregnatrienes; Time Factors; Vitamin E | 1991 |
[Effects of lipid peroxidation stimulation and inhibition on myoglobin and creatine kinase kinetics in uncomplicated and complicated forms of myocardial infarct].
Topics: Animals; Biochemical Phenomena; Biochemistry; Blood; Creatine Kinase; Dogs; Kinetics; Lipid Peroxidation; Myocardial Infarction; Myoglobin; Radioimmunoassay; Ultraviolet Rays; Vitamin E | 1991 |
Effect of a cardioselective alpha-tocopherol analogue on reperfusion injury in rats induced by myocardial ischaemia.
Topics: Animals; Benzopyrans; Carbon Radioisotopes; Creatine Kinase; Free Radical Scavengers; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Inbred Strains; Tissue Distribution; Vitamin E | 1991 |
[The expediency of optimizing lipid peroxidation in treating complicated forms of myocardial infarct healing].
Topics: Aminopyrine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood; Blood Transfusion, Autologous; Dogs; Drug Evaluation, Preclinical; Lipid Peroxidation; Lipopolysaccharides; Myocardial Infarction; Time Factors; Ultraviolet Therapy; Vitamin E | 1990 |
[Correction of metabolic disorders of the myocardium in acute myocardial infarct as an important factor in preventing the development of circulatory insufficiency].
Topics: Animals; Aprotinin; Ascorbic Acid; Drug Therapy, Combination; Glutamates; Glutamic Acid; Heart Failure; Ibuprofen; Myocardial Infarction; Myocardium; Nandrolone; Nandrolone Decanoate; Nifedipine; Potassium Magnesium Aspartate; Propranolol; Rabbits; Sodium Oxybate; Vitamin E | 1985 |
[Effects of essentiale forte on biosynthesis of nucleic acids and several hemodynamic parameters of the damaged myocardium in rabbits].
Topics: Adjuvants, Immunologic; Animals; Anticholesteremic Agents; DNA; Myocardial Infarction; Nucleic Acids; Phosphatidylcholines; Phospholipids; Platelet Aggregation Inhibitors; Rabbits; RNA; Vitamin E | 1989 |
[Effect of preliminary administration of alpha-tocopherol and intal on the course of experimental myocardial necrosis].
Topics: Animals; Capillaries; Coronary Circulation; Coronary Disease; Cromolyn Sodium; Disease Models, Animal; Male; Myocardial Infarction; Myocardium; Necrosis; Premedication; Rats; Vitamin E | 1989 |
[Effect of membrane protectors on the diastolic function of the heart in patients with acute myocardial infarction].
Topics: Adult; Aged; Cell Membrane; Diastole; Female; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Niacinamide; Vitamin E | 1989 |
Effect of vitamin E on the severity of myocardial infarction induced by isoproterenol.
Topics: Animals; Enzymes; Isoproterenol; Lipids; Male; Myocardial Infarction; Rats; Rats, Inbred Strains; Vitamin E | 1989 |
Effects of CV-3611, a new free radical scavenger, on ischemic heart failure in conscious beagle dogs.
Topics: Animals; Ascorbic Acid; Blood Pressure; Coronary Circulation; Coronary Disease; Dogs; Free Radicals; Heart Rate; Hemodynamics; Myocardial Infarction; Myocardial Reperfusion Injury; Vitamin E | 1989 |
Combined treatment with vitamins E and C in experimental myocardial infarction in pigs.
Topics: Animals; Ascorbic Acid; Drug Therapy, Combination; Free Radicals; Hemodynamics; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Swine; Vitamin E | 1989 |
Changes in plasma vitamin levels in the first 48 hours after onset of acute myocardial infarction.
Topics: Aged; beta Carotene; Calcifediol; Carotenoids; Case-Control Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors; Vitamin A; Vitamin E; Vitamins | 1989 |
Correlation between plasma levels of selenium and antithrombin-III.
Topics: Antithrombin III; Cholesterol; Female; Humans; Male; Middle Aged; Myocardial Infarction; Selenium; Specimen Handling; Triglycerides; Vitamin E | 1988 |
[Changes in the erythrocyte concentrations of various phospholipids-glycerides, erythrocyte peroxide resistance and plasma and erythrocyte alpha-tocopherol levels in acute myocardial infarct].
Topics: Acute Disease; Erythrocytes; Humans; Myocardial Infarction; Peroxides; Phospholipids; Time Factors; Vitamin E | 1987 |
Plasma vitamin A, E, C and B6 levels in myocardial infarction.
Topics: Adult; Aged; Ascorbic Acid; C-Reactive Protein; Humans; Middle Aged; Myocardial Infarction; Pyridoxine; Time Factors; Vitamin A; Vitamin E | 1987 |
[Effect of polyunsaturated fatty acids on the functional properties of the thrombocytes and on lipid peroxidation in ischemic heart disease patients].
Topics: Adenosine Diphosphate; Adult; Aged; Angina Pectoris; Blood Platelets; Chronic Disease; Coronary Disease; Drug Evaluation; Drug Therapy, Combination; Fatty Acids, Unsaturated; Humans; Lipid Peroxides; Male; Middle Aged; Myocardial Infarction; Oxidation-Reduction; Physical Exertion; Platelet Aggregation; Time Factors; Vitamin E | 1987 |
[Cardiomyocytes of the left ventricle of the heart in experimental infarct and pharmacostimulation (histochemical study)].
Topics: Animals; Chinchilla; Drug Therapy, Combination; Glycogen; Histocytochemistry; L-Lactate Dehydrogenase; Myocardial Infarction; Myocardium; Nucleic Acids; Succinate Dehydrogenase; Vitamin E | 1985 |
[Change in the alpha-tocopherol content of blood plasma and erythrocyte membranes in patients with myocardial infarct in the acute period].
Topics: Erythrocyte Membrane; Humans; Male; Myocardial Infarction; Vitamin E | 1985 |
An introductory note to ginseng.
Topics: Acupuncture Therapy; Adrenal Cortex Hormones; Adrenal Glands; Adrenocorticotropic Hormone; Animals; Ascorbic Acid; Blood Pressure; China; Environmental Exposure; Eosinophils; Guinea Pigs; Humans; Leukocyte Count; Medicine, East Asian Traditional; Myocardial Infarction; Panax; Phytotherapy; Plant Extracts; Plants, Medicinal; Rabbits; Rats; Stress, Physiological; Temperature; Vitamin E; Vitamins | 1973 |
Prolonged plasma clotting time and decreased fibrinolysis after long term treatment with alpha-tocopherol.
Topics: Blood Cell Count; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cell Membrane; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Adhesiveness; Time Factors; Vitamin E | 1974 |
[Vitamin E, unsaturated fatty acids, blood platelets and prostaglandins. A correction and addition].
Topics: Arteriosclerosis; Blood Platelets; Fatty Acids, Unsaturated; Humans; Myocardial Infarction; Prostaglandins; Vitamin E | 1973 |
Ozone, vitamin E, fatty acids, prostaglandins, atherosclerosis and its complications.
Topics: Animals; Arteriosclerosis; Environmental Exposure; Fatty Acids; Myocardial Infarction; Ozone; Prostaglandins; Vitamin E | 1973 |
Twenty-four years using alpha-tocopherol in degenerative cardiovascular disease.
Topics: Angina Pectoris; Arteriosclerosis; Cardiac Glycosides; Cardiovascular Diseases; Coronary Disease; Drug Synergism; Heart Failure; Humans; Myocardial Infarction; Thromboangiitis Obliterans; Thrombophlebitis; Vitamin E | 1970 |
On the protection against infarction by corn oil.
Topics: Animals; Chromatography; Diet, Atherogenic; Fats, Unsaturated; Fatty Acids, Essential; Linoleic Acids; Myocardial Infarction; Oils; Rats; Spectrophotometry; Sterols; Thrombosis; Ubiquinone; Vitamin E; Zea mays | 1968 |